Rigel Pharmaceuticals
Clinical trials sponsored by Rigel Pharmaceuticals, explained in plain language.
-
New hope for blood cancer patients: experimental drug targets resistant MDS
Disease control Recruiting nowThis study tests an experimental drug called R289 in adults with lower-risk myelodysplastic syndromes (MDS) whose disease has not improved with standard therapies. The main goals are to check the drug's safety and see if it can reduce or eliminate the need for red blood cell tran…
Phase: PHASE1, PHASE2 • Sponsor: Rigel Pharmaceuticals • Aim: Disease control
Last updated May 22, 2026 14:02 UTC
-
New study checks cancer Drug's impact on common medications
Knowledge-focused Recruiting nowThis study looks at how the cancer drug olutasidenib changes the way the body processes other medications. Researchers will give a mix of test drugs to 16 adults with IDH1-mutated cancers (like AML or certain brain tumors) and measure their levels in the blood before and after ol…
Phase: PHASE4 • Sponsor: Rigel Pharmaceuticals • Aim: Knowledge-focused
Last updated May 26, 2026 07:23 UTC